What are beneficial alternatives for patients who have refractory essential tremor? Four studies provide insight into the outcomes of high-intensity focused ultrasound.
On top of an extraordinary economic burden, caregivers of patients with Parkinson disease have higher rates of several general caregiving comorbidities, including backache, hypertension, and gastrointestinal symptoms.
A number of tools that clinicians can use to better understand their patients’ sleep quantity and quality.
Migraine sufferers who are trying to cut back on alcoholic beverages in 2019 may find additional motivation for their New Year’s resolution.
A review of existing guidelines and principles for treating migraine released by the American Headache Society.
Results from the largest global survey of its kind reveals that migraine sufferers who have not responded to preventive treatment experience a substantial burden of disease.
Findings from a pooled analysis of SWIFT and STAR studies analyzed whether IV thrombolysis added clinical benefit in acute ischemic stroke.
In case you missed the recent publication of these books, they are presented here for your library. Is there a recent book missing from this list you’d like to review, let us know!
I love this Rx site. I can look up all the drugs I can't afford.
Some migraine sufferers who do not initially respond to galcanezumab may show clinically meaningful improvement if they stay on the drug for longer periods of time.
From virtual examinations to neurology toolkits, these apps might prove helpful to your patients.
The CDC recently released the first US evidence-based guidelines on pediatric mild traumatic brain injury. Scroll through our quick slideshow to get the highlights.
In young patients with stroke without a clear cause, physicians should search for less common etiologies and treat accordingly.
This brief year-end slideshow highlights significant progress in research into migraine, Alzheimer disease, stroke, multiple sclerosis, and autism.
The progression of Parkinson disease and response to medication varies widely across individuals, which can make the prediction of disease course challenging.